A comprehensive individual patient data meta‐analysis of the effects of cardiac contractility modulation on functional capacity and heart failure‐related quality of life
Abstract Aims Cardiac contractility modulation, also referred to as CCM™, has emerged as a promising device treatment for heart failure (HF) in patients not indicated for cardiac resynchronization therapy. We performed a comprehensive individual patient data meta‐analysis of all non‐confounded prosp...
Main Authors: | Francesco Giallauria, Gianluigi Cuomo, Alessandro Parlato, Nirav Y. Raval, Jürgen Kuschyk, Andrew JS Stewart Coats |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-10-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.12902 |
Similar Items
-
Quality of life questionnaire predicts poor exercise capacity only in HFpEF and not in HFrEF
by: Artan Ahmeti, et al.
Published: (2017-10-01) -
Other Devices for Heart Failure — Cardiac Contractility Modulation (CCM)
by: Andrew J Stewart Coats
Published: (2017-01-01) -
Cardiac Contractility Modulation in Patients with Heart Failure with Reduced Left Ventricular Ejection Fraction
by: Francesco Giallauria, et al.
Published: (2021-03-01) -
Quality of life in heart failure patients using the Minnesota Living with Heart Failure Questionnaire (MLHF)
by: Soheyla Eskandari, et al.
Published: (2016-10-01) -
Modulation of Cardiac Contractility – a New Method in the Treatment of Heart Failure
by: A. A. Petrukhina, et al.
Published: (2016-11-01)